Focus & Mental Drive
Pay for 6 months, save 10-15%
Increased doses may be recommended for individuals with higher body weights or more severe health conditions, while reduced doses may be suitable for those with lower body weights or milder health issues
Cardiometabolic benefits: At 48 weeks, improvements included triglyceride reductions up to 40.6% and apoC-III reductions of 38%, along with substantial weight loss (24%) Post-hoc analysis uncovered reductions in albuminuria (3037%) and increased eGFR (8.5 mL/min/1.73 m), suggesting potential kidney-protective effects TRIUMPH-3 and TRIUMPH-OUTCOMES are ongoing Phase 3 studies targeting Cardiovascular safety and outcomes and Renal function in obese individuals with ASCVD or CKD Future with Other GLP-1 and GIP Analogues (Poly-agonists) The development of multi-receptor agonists like retatrutide is the next-generation leap beyond GLP-1 monotherapy, holding potential efficacy comparable to bariatric surgery with fewer GI limitations
Dosage for Mounjaro: What You Need to Know
Phentermine is a Schedule IV controlled substance and is contraindicated in patients with cardiovascular disease, uncontrolled high blood pressure, hyperthyroidism, and certain other conditions
